{"id":"W3198710304","doi":"10.1186/s12885-021-08453-9","title":"Quality of life analyses in patients with multiple myeloma: results from the Selinexor (KPT-330) Treatment of Refractory Myeloma (STORM) phase 2b study","year":2021,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"National Center for Advancing Translational Sciences; Karyopharm Therapeutics","keywords":"Medicine; Multiple myeloma; Clinical endpoint; Confidence interval; Internal medicine; Minimal clinically important difference; Quality of life (healthcare); Refractory (planetary science); Oncology; Post-hoc analysis; Clinical trial; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005228308,0.0005609511,0.000967426,0.0003280825,0.0001621458,0.0004924489,0.0003394388,0.0003870185,0.0008384215],"category_scores_gemma":[0.002249476,0.0001703978,0.001624931,0.0004470418,0.0002094717,0.0002709262,0.0005168439,0.0008066722,0.000129117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004464662,"about_ca_system_score_gemma":0.0003959551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004589514,"about_ca_topic_score_gemma":0.0006969197,"domain_scores_codex":[0.9985939,0.0009422235,0.00008204702,0.0001102031,0.0002096368,0.00006204875],"domain_scores_gemma":[0.9974526,0.0005973754,0.001168855,0.0001555858,0.0002317263,0.0003938407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2689155,0.007524772,0.5926071,0.0008970857,0.01409887,0.0001714049,0.0003021291,0.00536452,0.007791229,0.0001366106,0.003037783,0.09915292],"study_design_scores_gemma":[0.02758388,0.04125889,0.9236983,0.00004629583,0.002424278,0.0002388877,0.00006365988,0.002063619,0.001093075,0.000115995,0.001385216,0.00002794307],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941074,0.003401002,0.0002993953,0.0002167868,0.00001560591,0.0001783673,0.001327023,0.00001551527,0.0004389152],"genre_scores_gemma":[0.995551,0.0007493703,0.0006172052,0.0001896567,0.0000471893,0.00020862,0.002422859,0.000005817819,0.000208259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005228308,"threshold_uncertainty_score":0.0276503,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1444107409032521,"score_gpt":0.4286966444464539,"score_spread":0.2842859035432018,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}